Benzinga's Top Upgrades By: Benzinga via Benzinga November 14, 2016 at 08:46 AM EST Analysts at Credit Suisse upgraded PTC Therapeutics, Inc. (NASDAQ: PTCT) from Neutral to Outperform. The price target ... Read More >> Related Stocks: Actuant Corp Block Inc Centene Corp Citigroup Credit Suisse Group ADR Grubhub Ord Shs Kohl's Corp Lockheed Martin Ptc Therapeutics Quest Diagnostics